Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending September 2013. The report details a specific share repurchase transaction executed on September 16, 2013, in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share capital movements.
- Shares Purchased: 1,232,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,637.00 pence per share; lowest price paid was 1,614.00 pence per share.
- Treasury Holdings (Settled): 518,942,412 shares (9.58% of total issued share capital).
- Treasury Holdings (Including Unsettled): 522,639,412 shares (10.68% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,895,423,062 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,232,000 shares for Treasury. Consequently, the percentage of total voting rights held in Treasury increased to 10.68% when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (518,942,412 settled) against the company's latest annual report.
- Confirm the total issued share capital excluding Treasury shares (4,895,423,062) for voting rights calculations.
- Check the settlement status of the 1,232,000 shares purchased on September 16, 2013, to reconcile the difference between settled and total Treasury holdings.
- Review the price paid (1,614.00 to 1,637.00 pence) against the market price on September 16, 2013.